Skip to main content

ADVERTISEMENT

Daniele Severi-Bruni, MS

Research Reports
06/21/2021
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues...
06/21/2021
Journal of Clinical Pathways